PHARMACOKINETICS OF CEFOTAXIME

被引:91
作者
FU, KP
ASWAPOKEE, P
HO, I
MATTHIJSSEN, C
NEU, HC
机构
[1] COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,DIV INFECT DIS,NEW YORK,NY 10032
[2] HOECHST ROUSSEL PHARMACEUT INC,SOMERVILLE,NJ 08876
[3] COLUMBIA UNIV COLL PHYS & SURG,DEPT PHARMACOL,DIV INFECT DIS,NEW YORK,NY 10032
关键词
D O I
10.1128/AAC.16.5.592
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The pharmacokinetics of cefotaxime after intramuscular injection and intravenous infusion were determined. The mean peak serum level after the 500-mg intramuscular dose was 11.7 μg/ml, and it was 20.5 μg/ml after a 1,000-mg dose. The serum half-life was 1.2 and 1.3 h, respectively for the two doses. The apparent fractional volumes of distribution of 32 and 37 liters were not significantly different for the two doses, and the fractional serum clearance was approximately 315 ml/min per 1.73 m2 for both doses. The mean peak serum level after 1,000 mg administered by intravenous infusion over 30 min was 41.1 μg/ml. The half-life was 1.13 h, apparent volume of distribution was 33 liters, serum clearance 341 ml/min per 1.73 m2, and renal clearance was 130 ml/min per 1.73 m2. The pharmacology of cefotaxime is similar to the pharmacology of other cephalosporin antibiotics, but the low inhibitory levels which it has against gram-positive and gram negative bacteria suggest that lower dosage regimens should be possible.
引用
收藏
页码:592 / 597
页数:6
相关论文
共 11 条
[1]   COMPARATIVE PHARMACOKINETICS OF CEFAMANDOLE, CEPHAPIRIN, AND CEPHALOTHIN IN HEALTHY SUBJECTS AND EFFECT OF REPEATED DOSING [J].
BARZA, M ;
MELETHIL, S ;
BERGER, S ;
ERNST, EC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 10 (03) :421-425
[2]   SIMPLIFIED ACCURATE METHOD FOR ANTIBIOTIC ASSAY OF CLINICAL SPECIMENS [J].
BENNETT, JV ;
BRODIE, JL ;
BENNER, EJ ;
KIRBY, WMM .
APPLIED MICROBIOLOGY, 1966, 14 (02) :170-&
[3]  
BROGARD JM, 1978, J ANTIBIOT CHEMOTHER, V25, P123
[4]  
GRASAR FA, 1978, J ANTIMICROB CHEMOTH, V4, P445
[5]   EXPERIMENTAL EVALUATION OF HR-756, A NEW CEPHALOSPORIN DERIVATIVE - PRE-CLINICAL STUDY [J].
HEYMES, R ;
LUTZ, A ;
SCHRINNER, E .
INFECTION, 1977, 5 (04) :259-260
[6]  
METZLER CM, 1969, USERS MANUAL NONLIN
[7]   HR-756, A NEW CEPHALOSPORIN ACTIVE AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE AEROBIC AND ANAEROBIC BACTERIA [J].
NEU, HC ;
ASWAPOKEE, N ;
ASWAPOKEE, P ;
FU, KP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (02) :273-281
[8]  
NEU HC, 1978, J INFECT DIS S, V137, P80
[9]   PHARMACOKINETICS AND CLINICAL USE OF CEPHALOSPORIN ANTIBIOTICS [J].
NIGHTINGALE, CH ;
GREENE, DS ;
QUINTILIANI, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (12) :1899-1927
[10]   CSTRIP, A FORTRAN-4 COMPUTER-PROGRAM FOR OBTAINING INITIAL POLYEXPONENTIAL PARAMETER ESTIMATES [J].
SEDMAN, AJ ;
WAGNER, JG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (07) :1006-1010